Highly purified pharmaceutical grade tasimelteon
US10611744B2 · kind B2 · utility
10Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2018 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Sep 6, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/79
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.